References
- Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286:327–334.
- Ford ES. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care 1999;22:1971–1977.
- Orvieto R, Chen R, Ashkenazi J, Ben-Haroush A, Ben-Harush A, Bar J, Fisch B. C-reactive protein levels in patients undergoing controlled ovarian hyperstimulation for IVF cycle. Hum Reprod 2004;19:357–359.
- Almagor M, Hazav A, Yaffe H. The levels of C-reactive protein in women treated by IVF. Hum Reprod 2004;19:104–106.
- Levin I, Gamzu R, Pauzner D, Rogowski O, Shapira I, Maslovitz S, Almog B. Elevated levels of CRP in ovarian hyperstimulation syndrome: An unrecognised potential hazard? BJOG 2005;112:952–955.
- Levin I, Gamzu R, Mashiach R, Lessing JB, Amit A, Almog B. Higher C-reactive protein levels during IVF stimulation are associated with ART failure. J Reprod Immunol 2007;75:141–144.
- Arefi S, Babashamsi M, Shariatpanahi P, Shirazi ES. Effects of ovulation induction and ovarian puncture on CRP levels in subjects undergoing IVF/ICSI. J Reprod Infertil 2009;10:26.
- Wunder DM, Kretschmer R, Bersinger NA. Concentrations of leptin and C-reactive protein in serum and follicular fluid during assisted reproductive cycles. Hum Reprod 2005;20:1266–1271.
- Robinson S, Pemberton P, Laing I, Nardo LG. Low grade inflammation, as evidenced by basal high sensitivity CRP, is not correlated to outcome measures in IVF. J Assist Reprod Genet 2008;25:383–388.
- Sacks GP, Seyani L, Lavery S, Trew G. Maternal C-reactive protein levels are raised at 4 weeks gestation. Hum Reprod 2004;19:1025–1030.
- Pepys MB, Hirschfield GM. C-reactive protein: A critical update. J Clin Invest 2003;111:1805–1812.
- Wilcox AJ, Baird DD, Weinberg CR. Time of implantation of the conceptus and loss of pregnancy. N Engl J Med 1999;340:1796–1799.
- Liu HC, Rosenwaks Z. Early pregnancy wastage in IVF (in vitro fertilization) patients. J In Vitro Fert Embryo Transf 1991;8:65–72.
- Garlanda C, Maina V, Martinez de la Torre Y, Nebuloni M, Locati M. Inflammatory reaction and implantation: The new entries PTX3 and D6. Placenta 2008;29 Suppl B:129–134.
- Sheth KV, Roca GL, al-Sedairy ST, Parhar RS, Hamilton CJ, al-Abdul Jabbar F. Prediction of successful embryo implantation by measuring interleukin-1-α and immunosuppressive factor(s) in preimplantation embryo culture fluid. Fertil Steril 1991;55:952–957.
- Lindhard A, Bentin-Ley U, Ravn V, Islin H, Hviid T, Rex S, Bangsbøll S, Sørensen S. Biochemical evaluation of endometrial function at the time of implantation. Fertil Steril 2002;78:221–233.
- Mottla GL, Smotrich DB, Gindoff PR, Stillman RJ. Increasing clinical pregnancy rates after IVF/ET. Can immunosuppression help? J Reprod Med 1996;41:889–891.
- Rubinstein M, Marazzi A, Polak de Fried E. Low-dose aspirin treatment improves ovarian responsiveness, uterine and ovarian blood flow velocity, implantation, and pregnancy rates in patients undergoing in vitro fertilization: A prospective, randomized, double-blind placebo-controlled assay. Fertil Steril 1999;71:825–829.
- Daya S. Is there a benefit of low-dose aspirin in assisted reproduction? Curr Opin Obstet Gynecol 2006;18:313–318.
- Boomsma CM, Keay SD, Macklon NS. Peri-implantation glucocorticoid administration for assisted reproductive technology cycles. Cochrane Database Syst Rev 2007;24: CD005996.
- Poustie VJ, Dodd S, Drakeley AJ. Low-dose aspirin for in vitro fertilisation. Cochrane Database Syst Rev 2007;18: CD004832.
- Segev Y, Carp H, Auslender R, Dirnfeld M. Is there a place for adjuvant therapy in IVF? Obstet Gynecol Surv 2010;65:260–272.